Periodic Reporting for period 1 - OxygeAte (First long-lasting super-oxygenated water to promote post-exercise recovery and plant health, boosting crop yields sustainably)
Reporting period: 2018-07-01 to 2018-09-30
Two growing industries have their attention on the super-oxygenation of water: i)the healthy beverage industry is searching for a booster on functional bottled water and ii)the smart farming industry searching for more precise and sustainable irrigation technics for farming. The benefits achived with Oxygenate in these two industries are:
Super-Oxygenated Water (SOatedW) is a specialty consumer product for human health applications mostly unknown for common unhealthy humans, that only drink water and stretch if so after doing exercise (if so). Being athletic, increasing your performance and cutting down post-workout recovery are the most extensively medically verified applications of SOatedW. SOatedW helps the liver clear lactate, the product of fatigued muscles, speeding up recovery.
Super-Oxygenation (SOtion), simply put, enables more food production, richer in nutrients and using less resources. Crops need the Disolved Oxygen (DO) contained in water to survive and thrive. Plant growth increases with super saturation levels of DO, reducing cropping times and increasing fruiting or flowering yields. Several studies using SOtion point out to seasonal yield increase (over 10%), increased yield of early marketable products (13%) and reduced decline of production at end of season (16%). SOtion ultimately tackles one of the main challenges of our time: produce enough food for the growing human population, at the lowest resource use possible
We are focusing on our immediate launch in making it accessible for direct consumption via bottled water and for irrigation to make a healthy and long lifespan. Our aim will be to make our OxygenAte water commercially viable with new prototypes for producing our SOatedW for the bottled water sector and for irrigation purposes. We are confident in our ability to replicate strong evidence of the benefits of SOatedW for both human and plant consumption in order to overcome public doubt. This feasibility study assessed the likelihood of reaching a commercially ready prototype of OxygenAte for use in the bottled water and irrigation sectors and having significant evidence to back up the health and plant growth claims regarding SOatedW. From a commercial standpoint, the assessment explored the supply chain cycle and a strategy to reach potential customers.
We have proved this in our first series of medical tests and farm studies where our OxygenAte water has successfully raised oxygen levels in the blood and water which has supported more robust plant growth. Our first series of medical tests together with Østlandske Hjertesenter shows that OxygenAte water successfully increases the concentration of oxygen in the arterial blood by 22%. In parallel, our farm studies together with the Norwegian University of Life Sciences has shown that plants irrigated with OxygenAte water experience more robust plant growth for 10% higher yields and are better equipped to deal with higher temperatures.
We have applied for national funding for the design and development a new full-scale prototype which will be used for testing and further development of the commercial licencing versions of OxygenAte process machines for water bottlers and our OxygenIrrigAte machine to be integrated into smart irrigation systems. The next step will be to manufacture both prototypes to pilot their function in a commercially relevant environment and ensure their market readiness. Another important part of the commercial success of our technology will be to create strong branding and strengthen the value added to our customers. In order to do this, we have planned additional tests to be completed together with Østlandske Hjertesenter and Norwegian University of Life Sciences to solidify our health claims and benefits for plant growth. Moreover, we have conducted a freedom to operate analysis and developed the strategy to further increase our patent portfolio. Lastly, we have furthered our commercial efforts in finding partners interested in licensing Nitox’s technology once it is market ready, that support our pricing and “willingness to pay” assumptions. We already have interested clients in the pipeline for each of these segments who want to become leaders in offering this new technology, PepsiCo in the bottled water segment and RITEC in the irrigation segment.
We will strive to attain contracts for fixed amounts of production, roughly 3.5 million litres of bottled OxygenAte water annually per bottler-accounting for 4% of the water they currently produce. For the smart irrigation sector, we will aim to work with two smart irrigation providers at the beginning with the aim to sell 50 licenses each around Europe, starting in Spain and Italy. For the bottled water sector, our goal by 2023 will be to establish license agreements with 20 water bottlers (3.3% of all bottlers), starting in the European countries. We anticipate that we will generate roughly €7 million in sales from this channel alone by 2023. For the agricultural segment, our goal by 2023 will be to have acquired 900 licenses with farmers around Europe, 0.26% of the total market of large farmers in Europe, our main target market. By 2023, revenue generated from this stream will represent a significant part of our income (€12m).